ARK Genomic Revolution ETF vs iShares Core MSCI EAFE ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.79, while iShares Core MSCI EAFE ETF trades at $101.2. Which is the better fit depends on your goals.
| ARKG | IEFA | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $44.55 | $101.09 |
52-Week Low | $24.02 | $84.72 |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.
Read more on IEFA →